New Developments in Cancer VaccinesBUONAGURO, Luigi; AURISICCHIO, Luigi; BUONAGURO, Franco M et al.Expert review of vaccines. 2013, Vol 12, Num 10, issn 1476-0584, [126 p.]Serial Issue

Therapeutic vaccines : a solution to the prevention problem?DAWSON, Angus.Vaccine. 2005, Vol 23, Num 17-18, pp 2363-2366, issn 0264-410X, 4 p.Conference Paper

Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccineTALEBKHAN, Y; BABABEIK, M; ESMAEILI, M et al.Journal of microbiological methods. 2010, Vol 82, Num 3, pp 334-337, issn 0167-7012, 4 p.Article

Cell based cancer vaccines : Regulatory and commercial developmentCOPIER, John; WARD, Stephen; DALGLEISH, Angus et al.Vaccine. Supplement. 2007, Vol 25, Num 2, issn 1359-5938, B35-B46Article

Old and new vaccine approachesARNON, Ruth; BEN-YEDIDIA, Tamar.International immunopharmacology. 2003, Vol 3, Num 8, pp 1195-1204, issn 1567-5769, 10 p.Article

Exosomes as Immunotheranostic Nanoparticles : EXTRACELLULAR EXOSOMES AND MICROVESICLES IN ALLERGIC AND IMMUNOLOGICAL DISEASESNATASHA, G; GUNDOGAN, Buket; AARON TAN et al.Clinical therapeutics. 2014, Vol 36, Num 6, pp 820-829, issn 0149-2918, 10 p.Article

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccinesGIL, Cristina; CLIMENT, Nuria; PUMAROLA, Tomas et al.Vaccine. 2011, Vol 29, Num 34, pp 5711-5724, issn 0264-410X, 14 p.Article

Therapeutic Vaccines and Immunotherapies: Current Challenges and New FrontiersOVIEDO-ORTA, Ernesto; ULMER, Jeffrey B; AHMED, S. Sohail et al.Expert review of vaccines. 2013, Vol 12, Num 3, issn 1476-0584, [95 p.]Serial Issue

Tumor lysate-loaded biodegradable microparticles as cancer vaccinesJOSHI, Vijaya B; GEARY, Sean M; GROSS, Brett P et al.Expert review of vaccines. 2014, Vol 13, Num 1, pp 9-15, issn 1476-0584, 7 p.Article

Therapeutic vaccines against tobacco addictionFAHIM, Raafat Ef; KESSLER, Paul D; KALNIK, Matthew W et al.Expert review of vaccines. 2013, Vol 12, Num 3, pp 333-342, issn 1476-0584, 10 p.Article

Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccinesRINGVALL, Maria; HUIJBERS, Elisabeth J. M; AHOOGHALANDARI, Parvin et al.Vaccine. 2010, Vol 28, Num 1, pp 48-52, issn 0264-410X, 5 p.Article

BOOSTING T-CELL IMMUNITY AS A THERAPEUTIC APPROACH FOR NEURODEGENERATIVE CONDITIONS : THE ROLE OF INNATE IMMUNITY : Brain-Immune Interactions in Acute and Chronic Brain DisordersSCHWARTZ, M; LONDON, A; SHECHTER, R et al.Neuroscience. 2009, Vol 158, Num 3, pp 1133-1142, issn 0306-4522, 10 p.Article

Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccineJOHANSSON, Jeannette; HELLMAN, Lars.Vaccine. 2007, Vol 25, Num 9, pp 1676-1682, issn 0264-410X, 7 p.Article

Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine studyLI, Jonathan Z; HEISEY, Andrea; AHMED, Hayat et al.AIDS (London). 2014, Vol 28, Num 18, pp 2649-2657, issn 0269-9370, 9 p.Article

Immunosuppressive mechanisms in cancer: Consequences for the development of therapeutic vaccinesGROSS, Stefanie; GELDMACHER, Astrid; SHARAV, Tumenjargal et al.Vaccine. 2009, Vol 27, Num 25-26, pp 3398-3400, issn 0264-410X, 3 p.Conference Paper

Therapeutic cancer vaccines in the treatment of non-small-cell lung cancerLIMACHER, Jean-Marc; SPRING-GIUSTI, Clémentine; BELLON, Nadine et al.Expert review of vaccines. 2013, Vol 12, Num 3, pp 263-270, issn 1476-0584, 8 p.Article

Exploiting dendritic cells in the development of cancer vaccinesBRACCI, Laura; CAPONE, Imerio; MOSCHELLA, Federica et al.Expert review of vaccines. 2013, Vol 12, Num 10, pp 1195-1210, issn 1476-0584, 16 p.Article

A plasmid DNA immunogen expressing fifteen protein antigens and complex virus-like particles (VLP⁺) mimicking naturally occurring HIVSOMOGYI, Eszter; JIANQING XU; GUDICS, Agnes et al.Vaccine. 2011, Vol 29, Num 4, pp 744-753, issn 0264-410X, 10 p.Article

Of mice and not humans: How reliable are animal models for evaluation of herpes CD8⁺-T cell-epitopes-based immunotherapeutic vaccine candidates?DASGUPTA, Gargi; BENMOHAMED, Lbachir.Vaccine. 2011, Vol 29, Num 35, pp 5824-5836, issn 0264-410X, 13 p.Article

Ultra Scale-Down Stress Analysis of the Bioprocessing of Whole Human Cells as a Basis for Cancer VaccinesACOSTA-MARTINEZ, J. P; PAPANTONIOU, I; LAWRENCE, K et al.Biotechnology and bioengineering. 2010, Vol 107, Num 6, pp 953-963, issn 0006-3592, 11 p.Article

Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c miceZHENGJUN YI; YURONG FU; JIAN YANG et al.Vaccine. 2007, Vol 25, Num 4, pp 638-648, issn 0264-410X, 11 p.Article

A hydrophobic ligand-binding protein of the Taenia solium metacestode mediates uptake of the host lipid : Implication for the maintenance of parasitic cellular homeostasisLEE, Eung-Goo; KIM, Seon-Hee; BAE, Young-An et al.Proteomics (Weinheim. Print). 2007, Vol 7, Num 21, pp 4016-4030, issn 1615-9853, 15 p.Article

Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAgYIN HUANG; ZHI CHEN; HONGYU JIA et al.Clinical immunology (Orlando, Fla. Print). 2006, Vol 119, Num 3, pp 280-290, issn 1521-6616, 11 p.Article

Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigsDE ALUJA, Aline S; VILLALOBOS, Nelly M; NAVA, Gabriela et al.Vaccine. 2005, Vol 23, Num 31, pp 4062-4069, issn 0264-410X, 8 p.Article

Therapeutic vaccination for chronic infectious diseases : Lessons from HIV-1VERRIER, B.Journal of clinical virology. 2005, Vol 34, issn 1386-6532, S9-S12, SUP1Conference Paper